• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单结构域血管紧张素I转换酶(激肽酶II):特性与性质

Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.

作者信息

Deddish P A, Wang L X, Jackman H L, Michel B, Wang J, Skidgel R A, Erdös E G

机构信息

Department of Pharmacology, University of Illinois College of Medicine, Chicago, USA.

出版信息

J Pharmacol Exp Ther. 1996 Dec;279(3):1582-9.

PMID:8968386
Abstract

Somatic angiotensin I converting enzyme (ACE; kininase II) has two active sites, in two (N and C) domains. We studied the active centers with separate N-domain ACE (N-ACE), testicular C-domain ACE (germinal ACE) and, as control, renal somatic ACE. Germinal ACE cleaved the nonapeptide bradykinin about two times faster than N-ACE in 20 mM Cl-. Bradykinin1-7 was hydrolyzed further to bradykinin1-5 by N-ACE four times faster in the absence of Cl-, but at 300 mM Cl- the C-domain hydrolyzed it twice as fast. The hematopoietic system regulatory peptide acetyl-Ser-Asp-Lys-Pro was split to two dipeptides by N-ACE, depending on the chloride concentration, 8 to 24 times faster than by germinal ACE; at 100 mM Cl-, the Kcat with N-ACE was eight times higher. One millimolar 1-fluoro-2,4-dinitrobenzene inhibited germinal ACE 96% but it inhibited N-ACE by only 31%. [3H]Ramiprilat was displaced by other unlabeled ACE inhibitors to establish their relative affinities. Captopril had the lowest IC50 (0.5 nM) with N-ACE and the highest IC50 (8.3 nM) with the germinal ACE. The IC50 values of ramiprilat and quinaprilat were about the same with both active sites. The association and dissociation constants of [3H]ramiprilat indicated faster association with and faster dissociation from N-ACE than from germinal ACE. After exposure to alkali or moderate heat, somatic ACE was cleaved by plasmin and kallikrein, releasing N-ACE and apparently inactivating the C-domain. These studies affirm the differences in the activity, stability and inhibition of the two active sites of ACE.

摘要

体细胞血管紧张素I转换酶(ACE;激肽酶II)在两个(N和C)结构域中有两个活性位点。我们用分离的N结构域ACE(N-ACE)、睾丸C结构域ACE(生殖ACE)以及作为对照的肾体细胞ACE研究了活性中心。在20 mM Cl-中,生殖ACE切割九肽缓激肽的速度比N-ACE快约两倍。在无Cl-的情况下,N-ACE将缓激肽1-7进一步水解为缓激肽1-5的速度快四倍,但在300 mM Cl-时,C结构域水解它的速度快两倍。造血系统调节肽乙酰-Ser-Asp-Lys-Pro被N-ACE切割成两个二肽,这取决于氯化物浓度,比生殖ACE快8至24倍;在100 mM Cl-时,N-ACE的催化常数Kcat高八倍。1 mM 1-氟-2,4-二硝基苯抑制生殖ACE 96%,但仅抑制N-ACE 31%。用其他未标记的ACE抑制剂取代[3H]雷米普利拉以确定它们的相对亲和力。卡托普利对N-ACE的IC50最低(0.5 nM),对生殖ACE的IC50最高(8.3 nM)。雷米普利拉和喹那普利拉的IC50值在两个活性位点大致相同。[3H]雷米普利拉的结合和解离常数表明,与生殖ACE相比,它与N-ACE的结合更快,解离也更快。暴露于碱或适度加热后,体细胞ACE被纤溶酶和激肽释放酶切割,释放出N-ACE,显然使C结构域失活。这些研究证实了ACE两个活性位点在活性、稳定性和抑制方面的差异。

相似文献

1
Single-domain angiotensin I converting enzyme (kininase II): characterization and properties.单结构域血管紧张素I转换酶(激肽酶II):特性与性质
J Pharmacol Exp Ther. 1996 Dec;279(3):1582-9.
2
Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors.体细胞血管紧张素转换酶的两个活性位点在血管紧张素I和缓激肽裂解中的作用:来自选择性抑制剂的见解。
Circ Res. 2003 Jul 25;93(2):148-54. doi: 10.1161/01.RES.0000081593.33848.FC. Epub 2003 Jun 12.
3
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE.血管紧张素转换酶(ACE)抑制剂对人体体细胞ACE的缓激肽结合位点具有不同的选择性。
Eur J Pharmacol. 2007 Dec 22;577(1-3):1-6. doi: 10.1016/j.ejphar.2007.07.061. Epub 2007 Aug 3.
4
Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.联合使用选择性抑制剂和荧光底物研究体细胞野生型血管紧张素转换酶的特异性。
FEBS J. 2006 Apr;273(8):1772-81. doi: 10.1111/j.1742-4658.2006.05196.x.
5
[Angiotensin converting enzyme (kininase II). Molecular and physiological aspects].[血管紧张素转换酶(激肽酶II)。分子与生理学方面]
C R Seances Soc Biol Fil. 1992;186(6):586-98.
6
Estimation of rate constants for reactions of pulmonary microvascular angiotensin converting enzyme with an inhibitor and a substrate in vivo.体内肺微血管血管紧张素转换酶与抑制剂和底物反应速率常数的估算。
J Pharmacol Exp Ther. 1994 Jul;270(1):260-8.
7
Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.RXPA380的结构决定因素,一种有效的且高度选择性的血管紧张素转换酶C结构域抑制剂。
Biochemistry. 2004 Jun 29;43(25):8048-54. doi: 10.1021/bi049504q.
8
Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.牛肺和睾丸血管紧张素转换酶的血管紧张素I转换及激肽降解活性的抑制剂分析
Biochemistry (Mosc). 1999 Aug;64(8):938-44.
9
Development of domain-selective angiotensin I-converting enzyme inhibitors.区域选择性血管紧张素I转换酶抑制剂的研发
Ann N Y Acad Sci. 2005 Nov;1056:160-75. doi: 10.1196/annals.1352.035.
10
Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).新型肽抑制剂对二肽基羧肽酶(血管紧张素转换酶)的血管紧张素I转换活性与激肽降解活性之比的影响
Biochemistry (Mosc). 1997 Mar;62(3):247-50.

引用本文的文献

1
Bradykinin B2 Receptor Signaling Increases Glucose Uptake and Oxidation: Evidence and Open Questions.缓激肽B2受体信号传导增加葡萄糖摄取与氧化:证据与未决问题
Front Pharmacol. 2020 Aug 4;11:1162. doi: 10.3389/fphar.2020.01162. eCollection 2020.
2
Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.血管紧张素转换酶水解Ac-SDKP的结构基础
Sci Rep. 2015 Sep 25;5:13742. doi: 10.1038/srep13742.
3
Angiotensin I-converting enzyme Gln1069Arg mutation impairs trafficking to the cell surface resulting in selective denaturation of the C-domain.
血管紧张素转换酶 Gln1069Arg 突变会损害其向细胞表面的转运,导致 C 结构域的选择性变性。
PLoS One. 2010 May 3;5(5):e10438. doi: 10.1371/journal.pone.0010438.
4
Angiotensin I-converting enzyme inhibitors are allosteric enhancers of kinin B1 and B2 receptor function.血管紧张素转化酶抑制剂是激肽 B1 和 B2 受体功能的变构增强剂。
Hypertension. 2010 Feb;55(2):214-20. doi: 10.1161/HYPERTENSIONAHA.109.144600. Epub 2010 Jan 11.
5
Characterization of dipeptidylcarboxypeptidase of Leishmania donovani: a molecular model for structure based design of antileishmanials.杜氏利什曼原虫二肽羧基肽酶的特性:基于结构的抗利什曼原虫药物设计的分子模型。
J Comput Aided Mol Des. 2010 Jan;24(1):77-87. doi: 10.1007/s10822-009-9315-y. Epub 2009 Dec 29.
6
Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat.用于血管紧张素转换酶抑制剂的人体生理药代动力学模型:雷米普利和雷米普利拉。
BMC Clin Pharmacol. 2006 Jan 6;6:1. doi: 10.1186/1472-6904-6-1.
7
Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.用于人类体细胞血管紧张素转换酶结构域间合作的动力学探针
Biochem J. 2005 Nov 1;391(Pt 3):641-7. doi: 10.1042/BJ20050702.
8
RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.RXP 407是一种次膦酸肽,是一种能够区分血管紧张素I转换酶两个活性位点的强效抑制剂。
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4330-5. doi: 10.1073/pnas.96.8.4330.